ALK and neuroblastoma: In addition, ALK mutations have been identified in both low- and high-risk neuroblastoma with equal frequency (Bresler et al., 2014), suggesting that activated ALK cooperates with other oncogenic aberrations to define high- versus low-risk tumors.